Biodesign Directory Profile
Karen Kibler
Assistant Research Professor
The Biodesign Institute, Infectious Diseases and Vaccinology
Bio
Publications
- Kibler, KV, Gomez, CE, Perdiguero, B, Wong, S, Huynh, T, Holechek, S, Arndt, W, Jimenez, V, Gonzalez-Sanz, R, Denzler, K, Haddad, EK, Wagner, R, Sekaly, RP, Tartaglia, J, Pantaleo, G, Jacobs, BJ, and Esteban, M. Improved NYVAC-Based Vaccine Vectors. PLoS ONE, 2011.
- E.D. Quakkelaar, A. Redeker, E.K. Haddad, A. Harari, S. Mayo McCaughey, T. Duhen, A. Filali-Mouhim, J.P. Goulet, N.M. Loof, F. Ossendorp, B. Perdiguero, P. Heinen, C.E. Gomez, K. Kibler, D.M. Koelle5, R.P. Sékaly, F. Sallusto, A. Lanzavecchia, G. Pantaleo, M. Esteban, J. Tartaglia, B. Jacobs and C.J.M. Melief. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS ONE, 2010.
- Tsen, K.T., Tsen, S.W., Fu, Q., Lindsay, S.M., Kibler, K., Jacobs, B., Wu, T.C., Karanam, B., Jagu, S., Roden, R.B., Hung, C.F., Sankey, O.F., Ramakrishna, B. and Kiang, J.G. (2009) Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser. J Biomed Opt 14(6), 064042.
- Jentarra GM, Heck MC, Youn JW, Kibler K, Langland JO, Baskin CR, Ananieva O, Chang Y, Jacobs BL.
2008. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination. Vaccine, 26(23):2860-72. - Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki, M, Radkowski M, Nasseri J, Rakela J, Laskus T. 2006. Selection of different 5'untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection. J Viral Hep, 13(7):489-98.